Compound Detail
CHEMBL1214124
PERAMPANEL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1214124 |
| Name | PERAMPANEL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PRMWGUBFXWROHD-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
3
Targets
10
Activities
1
Assay Types
11
PK Parameters
20
Publications
5
Known Names
17
Indications
1
Mechanisms
Molecular Properties
349.4
MW (Da)
4.44
ALogP
4
HBA
0
HBD
58.7
PSA (Ų)
0.55
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2012 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Glutamate receptor ionotropic AMPA antagonist | ANTAGONIST | Glutamate receptor ionotropic AMPA | ✓ | ✓ |
Indications
Epilepsies, Partial Epilepsy Seizures Epilepsy, Tonic-Clonic Epilepsy, Tonic-Clonic Lennox Gastaut Syndrome Parkinson Disease Amyotrophic Lateral Sclerosis Diabetic Neuropathies Essential Tremor Migraine Disorders Neuralgia Small Fiber Neuropathy Alcoholism Bipolar Disorder Depressive Disorder, Major Torticollis
ATC Classification
N03AX22
perampanel
Level 1: NERVOUS SYSTEM
Level 2: ANTIEPILEPTICS
Activity Summary
IC50 10 meas. best 7.22
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 7.22 | 5.5625 | 60.0 | 4 |
| Glutamate receptor 1 CHEMBL2009 | IC50 | 6.61 | 6.05 | 243.0 | 5 |
| Glutamate receptor 3 CHEMBL3595 | IC50 | 5.68 | 5.68 | 2100.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 360.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 560.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 0.108 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 0.02 | mL.min-1.g-1 | Mus musculus |
| CL | 0.009 | mL.min-1.g-1 | Homo sapiens |
| CL | 30.33 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 486.56 | nM | Rattus norvegicus |
| F | 64.3 | % | Rattus norvegicus |
| T1/2 | 70.0 | hr | Homo sapiens |
| T1/2 | 2.37 | hr | Rattus norvegicus |
| Tmax | 0.5 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30891119 | 10.1021/acsmedchemlett.8b00322 | Glutamate receptor 3 | 18 |
| 23181587 | 10.1021/jm301268u | Rattus norvegicus | 8 |
| 27067148 | 10.1021/acs.jmedchem.6b00125 | Glutamate receptor 1 | 5 |
| 23181587 | 10.1021/jm301268u | Mus musculus | 4 |
| 20356304 | 10.1021/jm901688m | Mus musculus | 3 |
| 23181587 | 10.1021/jm301268u | Nucleic Acid | 3 |
| 27067148 | 10.1021/acs.jmedchem.6b00125 | Rattus norvegicus | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-dependent L-type calcium channel subunit alpha-1C | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 33324471 | 10.1021/acsmedchemlett.0c00521 | Unchecked | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 2 |
| 23181587 | 10.1021/jm301268u | Liver microsomes | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 2 |
Data from ChEMBL 36 via Core Engine